
BIOX Stock Forecast & Price Target
BIOX Analyst Ratings
Bulls say
Bioceres Crop Solutions Corp has demonstrated resilience in its Crop Protection portfolio, with notable strength observed outside of Argentina, which positions the company favorably for potential recoveries in the local market. The firm is also focusing on international opportunities for its HB4 wheat product, anticipating significant revenue growth from markets in the US, Brazil, and Australia, despite the gradual ramp-up of revenue as partnerships are established. Additionally, the overall performance has been supplemented by robust sales in bio-protection products in the US and Latin America, as well as increased adjuvant sales in Brazil, mitigating weaker results from the Argentine market.
Bears say
Bioceres Crop Solutions has experienced significant revenue declines, particularly in its Crop Protection and Crop Nutrition segments, driven by weaker demand in Argentina and reduced contributions from HB4-related sales. Specifically, the Crop Nutrition segment saw a year-over-year decrease of approximately 34%, attributed to softer market demand and pricing pressures in Argentina's fertilizer markets, further impacted by lower corn acreage. Additionally, the company's transition to a licensing-based business model led to a dramatic 75% year-over-year drop in Seed & Integrated products revenue, reflecting the challenges associated with exiting its traditional seed production and sales operations.
This aggregate rating is based on analysts' research of Bioceres Crop Solutions Corp and is not a guaranteed prediction by Public.com or investment advice.
BIOX Analyst Forecast & Price Prediction
Start investing in BIOX
Order type
Buy in
Order amount
Est. shares
0 shares